Plant Comparison
Chaga vs Bay Leaf
A side-by-side comparison of two medicinal plants — every documented constituent, action, use, safety note and cited source, assembled automatically from the Omnia Sana database.
At a glance
Chaga and Bay Leaf: they share 7 indicated uses (arthritis / joint pain, cancer (anticancer research), infection (general), …); 5 pharmacological actions in common.
Evidence face-off — shared uses
| Condition | Chaga | Bay Leaf | Verdict |
|---|---|---|---|
| Arthritis / joint pain | 1/10 | 1/10 | Comparable evidence |
| Cancer (anticancer research) | 2/10 | 2/10 | Comparable evidence |
| Infection (general) | 1/10 | 1/10 | Comparable evidence |
| Inflammation (general) | 1/10 | 1/10 | Comparable evidence |
| Skin irritation | 1/10 | 1/10 | Comparable evidence |
| Wounds | 1/10 | 1/10 | Comparable evidence |
| Cognitive function | 2/10 | 1/10 | Comparable evidence |
Evidence scores (1–10) are computed from the tier of each cited source. “Comparable” means the two scores are within one point. Follow a score to its detailed sources.
Key Constituents
Chaga's dark colour comes from melanin-like pigments; it also concentrates betulinic-acid-type triterpenes absorbed from its birch host, associated with antioxidant and anticancer research interest.
Immunomodulatory polysaccharides contributing to the traditional tonic and immune-support use.
Antioxidant phenolics contributing to chaga's free-radical-scavenging activity.
Leaf essential oil dominated by 1,8-cineole and eugenol, giving the characteristic aroma and much of the antimicrobial and anti-inflammatory activity.
Contribute to the plant's anti-inflammatory and antioxidant activity.
Pharmacological Actions
Traditional & Indicated Uses
inferred from anti-inflammatory action
inferred from anticancer action
inferred from immunomodulator action
inferred from antimicrobial action
inferred from anti-inflammatory action
inferred from anti-inflammatory action
Chaga-derived 3,4-DHBA protected against Parkinson's-related neurotoxicity (preclinical).
Chaga polysaccharide lowered lipids in vivo and in vitro.
inferred from anti-inflammatory action
inferred from analgesic action
inferred from digestive action
inferred from vulnerary action
inferred from anticancer action
inferred from neuroprotective action
inferred from analgesic action
inferred from digestive action
inferred from antimicrobial action
inferred from anti-inflammatory action
inferred from neuroprotective action
inferred from anti-inflammatory action
Safety, Cautions & Contraindications
Autoimmune conditions: Chaga can stimulate parts of the immune system—people with autoimmune diseases should be cautious.Blood thinners: Chaga contains compounds that may affect clotting—avoid large doses if on anticoagulants.Blood sugar meds: May slightly lower glucose—monitor if taking diabetes medication.Pregnancy & breastfeeding: Limited safety data—best avoided unless guided by a professional.Quality matters: Wild-harvested Chaga can accumulate heavy metals from trees and soil—source from reputable suppliers.
Generally safe when used in food amounts. Not toxic to people and safe to cook with. Leaves are very rigid and leathery - should be removed before eating as they don't soften with cooking and edges can be sharp. Insufficient reliable information about safety during pregnancy or breastfeeding - stick to food amounts. Large amounts of bay leaf tea may cause vomiting (emetic properties) and drowsiness (sedative properties). In high doses, bay laurel has cytotoxic activity. Some people may experience allergic contact dermatitis from bay laurel oil.
Duke (2002) notes antibacterial, anti-inflammatory, and antioxidant activities for bay laurel, primarily at the experimental level. The essential oil contains eugenol and 1,8-cineole as principal bioactive components. Traditional dosages in European phytotherapy include 1–3 g of dried leaf as a tea. Caution is advised as the essential oil may cause allergic contact dermatitis, and bay berries should not be confused with the less toxic leaves (Duke, 2002).
External Ids
Botanical Description
Parasitic wood-decay fungus (not a true plant) that grows almost entirely inside the trunk of living birch trees, visible externally only as a hard, black, cracked, charcoal-like mass (a sclerotium, sometimes called a 'conk') erupting through the bark. Unlike typical mushrooms, chaga has no true cap, gills or stem; its fertile spore-producing surface develops later, hidden beneath the bark after the tree dies.[1]
Evergreen shrub or small tree with dark green, glossy, aromatic leaves, smooth-edged and slightly wavy at the margin. Small, pale yellow-green flowers are borne in clusters in the leaf axils in spring, followed by small, dark purple-black berries on female trees.[11]
Habitat
Grows almost exclusively as a parasite on living birch trees in cold, northern temperate and boreal forests of Europe, Russia, North America and Asia.[1]
Native to the Mediterranean region; widely cultivated as a culinary herb and ornamental tree in warm-temperate and Mediterranean climates worldwide.[11]
Harvesting
The hard black external mass (conk) is chopped or broken away from the living birch trunk, ideally without killing the tree, then dried and broken into pieces or ground for use; sustainable harvesting (leaving part of the conk to regrow) is recommended given the fungus's slow growth.
Leaves are picked year-round from established plants and used fresh or dried; berries/seed are collected once ripe in autumn.
Traditional Uses
Chaga has a long traditional use in Russian, Siberian, Baltic and Scandinavian folk medicine as a tonic remedy for digestive complaints, immune support and general vitality, traditionally taken as a dark, tea-like decoction; this traditional tonic reputation is now studied for its antioxidant, immunomodulatory and anti-inflammatory properties.[1, 4]
Bay leaf has an ancient Mediterranean culinary and medicinal history, used as a digestive carminative for indigestion and bloating, and topically and traditionally for muscle and joint pain and minor wounds; it remains one of the most widely used culinary herbs worldwide.[11]
Preparations
Dried leaf infused in hot water as a traditional digestive tea.
References
Lookalikes Review
Dosage
Not documented
Two clinical studies in healthy volunteers used an infusion prepared from 5 g of dried Laurus nobilis leaves in 100 mL of boiled water, taken once daily for 10 days. Traditional references suggest a smaller 1-3 g per cup up to three times daily; no EMA or WHO monograph exists for bay leaf. Educational reference only, not a prescription.
Dangerous Lookalikes
Not documented
References & Sources
- Camilleri, E., Blundell, R., Baral, B., Karpinski, T.M. et al (2024) 'A brief overview of the medicinal and nutraceutical importance of Inonotus obliquus (chaga) mushrooms', Heliyon, 10(15), pp. e35638. doi:10.1016/j.heliyon.2024.e35638 Traditional / reference
https://doi.org/10.1016/j.heliyon.2024.e35638 - Lu, Y., Jia, Y., Xue, Z., Li, N. et al (2021) 'Recent Developments in Inonotus obliquus (Chaga mushroom) Polysaccharides: Isolation, Structural Characteristics, Biological Activities and Application', Polymers (Basel), 13(9), pp. 1441. doi:10.3390/polym13091441 Traditional / reference
https://doi.org/10.3390/polym13091441 - Kobus, Z., Krzywicka, M., Blicharz-Kania, A., Bosacka, A. et al (2024) 'Impact of Incorporating Dried Chaga Mushroom (Inonotus obliquus) into Gluten-Free Bread on Its Antioxidant and Sensory Characteristics', Molecules, 29(16), pp. 3801. doi:10.3390/molecules29163801 Preclinical
https://doi.org/10.3390/molecules29163801 - Szychowski, K.A., Skora, B., Pomianek, T. and Gminski, J (2020) 'Inonotus obliquus - from folk medicine to clinical use', Journal of Traditional and Complementary Medicine, 11(4), pp. 293-302. doi:10.1016/j.jtcme.2020.08.003 Meta-analysis / review
https://doi.org/10.1016/j.jtcme.2020.08.003 - Javed, S., Mitchell, K., Sidsworth, D., Sellers, S.L., Reutens-Hernandez, J., Massicotte, H.B., Egger, K.N., Lee, C.H. and Payne, G.W (2019) 'Inonotus obliquus attenuates histamine-induced microvascular inflammation', PLoS One, 14(8), pp. e0220776. doi:10.1371/journal.pone.0220776 Preclinical
https://doi.org/10.1371/journal.pone.0220776 - Zou, C., Hou, Z., Bai, M., Guo, R., Lin, B., Wang, X., Huang, X. and Song, S (2020) 'Highly modified steroids from Inonotus obliquus', Organic & Biomolecular Chemistry, 18(20), pp. 3908-3916. doi:10.1039/d0ob00474j Preclinical
https://doi.org/10.1039/d0ob00474j - Zhong, X.H., Ren, K., Lu, S.J., Yang, S.Y. and Sun, D.Z (2009) 'Progress of research on Inonotus obliquus', Chinese Journal of Integrative Medicine, 15(2), pp. 156-160. doi:10.1007/s11655-009-0156-2 Meta-analysis / review
https://doi.org/10.1007/s11655-009-0156-2 - Burmasova, M.A., Utebaeva, A.A., Sysoeva, E.V. and Sysoeva, M.A (2019) 'Melanins of Inonotus obliquus: bifidogenic and antioxidant properties', Biomolecules, 9(6), pp. 248. doi:10.3390/biom9060248 Preclinical
https://doi.org/10.3390/biom9060248 - Sun, Y., Deng, X., Li, Z., Dong, Y., Jiang, W., Ma, Y., Zhou, W., Zhu, T., Wang, G., Liu, S. and Hu, B (2022) 'Polysaccharide derived from Inonotus obliquus inhibits lipopolysaccharide-induced acute endometritis in mice', American Journal of Translational Research, 14(11), pp. 8332-8342. Preclinical
https://scholar.google.com/scholar?q=Polysaccharide%20derived%20from%20Inonotus%20obliquus%20inhibits%20lipopolysaccharide-induced%20acute%20endometritis%20in%20mice - Ishfaq, P.M., Mishra, S., Mishra, A., Ahmad, Z., Gayen, S., Jain, S.K., Tripathi, S. and Mishra, S.K (2022) 'Inonotus obliquus aqueous extract prevents histopathological alterations in liver induced by environmental toxicant Microcystin', Current Research in Pharmacology and Drug Discovery, 3, pp. 100118. doi:10.1016/j.crphar.2022.100118 Preclinical
https://doi.org/10.1016/j.crphar.2022.100118 - Peng, A., Liu, S., Fang, L., Zhu, Z., Zhou, Y., Yue, S., Ma, Z., Liu, X., Xue, S., Qiu, Y. and Qi, R (2022) 'Inonotus obliquus and its bioactive compounds alleviate non-alcoholic fatty liver disease via regulating FXR/SHP/SREBP-1c axis', European Journal of Pharmacology, 921, pp. 174841. doi:10.1016/j.ejphar.2022.174841 Preclinical
https://doi.org/10.1016/j.ejphar.2022.174841 - Zhang, Y., Liu, Q., Sun, Y. and Jiang, J (2023) 'Inonotus obliquus sclerotia epidermis were different from internal tissues in compound composition, antioxidant activity, and associated fungi', FEMS Microbiology Letters, 370, pp. fnad126. doi:10.1093/femsle/fnad126 Preclinical
https://doi.org/10.1093/femsle/fnad126 - Yu, S., Lai, Z., Xue, H., Zhu, J., Yue, G., Wang, J. and Jin, L.H (2024) 'Inonotus obliquus aqueous extract inhibits intestinal inflammation and insulin metabolism defects in Drosophila', Toxicology Mechanisms and Methods, 34(9), pp. 970-984. doi:10.1080/15376516.2024.2368795 Preclinical
https://doi.org/10.1080/15376516.2024.2368795 - Wold, C.W. and Christopoulos, P. and Arias, M. and Dzovor, D.E. and Øynebråten, I. and Corthay, A. and Inngjerdingen, K.T (2024) 'Fungal polysaccharides from Inonotus obliquus are agonists for Toll-like receptors and induce macrophage anti-cancer activity', Communications Biology. doi:10.1038/s42003-024-05853-y Preclinical
https://doi.org/10.1038/s42003-024-05853-y - Li, J. and Qu, C. and Li, F. and Chen, Y. and Zheng, J. and Xiao, Y. and Jin, Q. and Jin, G. and Huang, X. and Jin, D (2021) 'Inonotus obliquus Polysaccharide Ameliorates Azoxymethane/Dextran Sulfate Sodium-Induced Colitis-Associated Cancer in Mice via Activation of the NLRP3 Inflammasome', Frontiers in Pharmacology. doi:10.3389/fphar.2020.621835 Preclinical
https://doi.org/10.3389/fphar.2020.621835 - Wold, C.W. and Gerwick, W.H. and Wangensteen, H. and Inngjerdingen, K.T (2020) 'Bioactive triterpenoids and water-soluble melanin from Inonotus obliquus (Chaga) with immunomodulatory activity', Journal of Functional Foods. doi:10.1016/j.jff.2020.104025 Preclinical
https://doi.org/10.1016/j.jff.2020.104025 - Kim, J. and Yang, S. and Hwang, A.Y. and Cho, H. and Hwang, K.T (2020) 'Composition of Triterpenoids in Inonotus obliquus and Their Anti-Proliferative Activity on Cancer Cell Lines', Molecules. doi:10.3390/molecules25184066 Preclinical
https://doi.org/10.3390/molecules25184066 - Duru, K.C. and Kovaleva, E.G. and Данилова, И.Г. and Bijl, P.V.D (2019) 'The pharmacological potential and possible molecular mechanisms of action of Inonotus obliquus from preclinical studies', Phytotherapy Research. doi:10.1002/ptr.6384 Preclinical
https://doi.org/10.1002/ptr.6384 - Hu, Y. and Teng, C. and Yu, S. and Wang, X. and Liang, J. and Bai, X. and Dong, L. and Song, T. and Yu, M. and Qu, J (2017) 'Inonotus obliquus polysaccharide regulates gut microbiota of chronic pancreatitis in mice', AMB Express. doi:10.1186/s13568-017-0341-1 Preclinical
https://doi.org/10.1186/s13568-017-0341-1 - Chou, Y. and Kan, W. and Chang, C. and Peng, Y. and Wang, H. and Yu, W. and Cheng, Y. and Jhang, Y. and Liu, H. and Chuu, J (2016) 'Renal Protective Effects of Low Molecular Weight of Inonotus obliquus Polysaccharide (LIOP) on HFD/STZ-Induced Nephropathy in Mice', International Journal of Molecular Sciences. doi:10.3390/ijms17091535 Preclinical
https://doi.org/10.3390/ijms17091535 - Arata, S. and Watanabe, J. and Maeda, M. and Yamamoto, M. and Matsuhashi, H. and Mochizuki, M. and Kagami, N. and Honda, K. and Inagaki, M (2016) 'Continuous intake of the Chaga mushroom (Inonotus obliquus) aqueous extract suppresses cancer progression and maintains body temperature in mice', Heliyon. doi:10.1016/j.heliyon.2016.e00111 Preclinical
https://doi.org/10.1016/j.heliyon.2016.e00111 - Lee, K.R. and Lee, J.S. and Kim, Y.R. and Song, I.G. and Hong, E.K (2014) 'Polysaccharide from Inonotus obliquus inhibits migration and invasion in B16-F10 cells by suppressing MMP-2 and MMP-9 via downregulation of NF-κB signaling pathway', Oncology Reports. doi:10.3892/or.2014.3103 Preclinical
https://doi.org/10.3892/or.2014.3103 - Song, F. and Liu, Y. and Kong, X. and Chang, W. and Song, G (2013) 'Progress on Understanding the Anticancer Mechanisms of Medicinal Mushroom: Inonotus Obliquus', Asian Pacific Journal of Cancer Prevention. doi:10.7314/apjcp.2013.14.3.1571 Preclinical
https://doi.org/10.7314/apjcp.2013.14.3.1571 - Gunjima, K. and Tomiyama, R. and Takakura, K. and Yamada, T. and Hashida, K. and Nakamura, Y. and Konishi, T. and Matsugo, S. and Hori, O (2013) '3,4‐Dihydroxybenzalacetone Protects Against Parkinson's Disease‐Related Neurotoxin 6‐OHDA Through Akt/Nrf2/Glutathione Pathway', Journal of Cellular Biochemistry. doi:10.1002/jcb.24643 Preclinical
https://doi.org/10.1002/jcb.24643 - Geng, Y. and Lu, Z. and Huang, W. and Xu, H. and Shi, J. and Xu, Z (2013) 'Bioassay-Guided Isolation of DPP-4 Inhibitory Fractions from Extracts of Submerged Cultured of Inonotus obliquus', Molecules. doi:10.3390/molecules18011150 Preclinical
https://doi.org/10.3390/molecules18011150 - Zhang, L. and Fan, C. and Liu, S. and Zang, Z. and Jiao, L. and Zhang, L (2011) 'Chemical composition and antitumor activity of polysaccharide from Inonotus obliquus', Journal of Medicinal Plants Research. doi:10.5897/jmpr.9000346 Preclinical
https://doi.org/10.5897/jmpr.9000346 - Choi, S. and Hur, S.J. and An, C.S. and Jeon, Y.H. and Jeoung, Y.J. and Bak, J.P. and Lim, B.O (2010) 'Anti-Inflammatory Effects ofInonotus obliquusin Colitis Induced by Dextran Sodium Sulfate', Journal of Biomedicine and Biotechnology. doi:10.1155/2010/943516 Preclinical
https://doi.org/10.1155/2010/943516 - Youn, M. and Kim, J. and Park, S. and Kim, Y. and Kim, S. and Lee, J.S. and Chai, K.Y. and Kim, H. and Cui, M. and So, H.S. and Kim, K. and Park, R (2008) 'Chaga mushroom (Inonotus obliquus ) induces G0/G1 arrest and apoptosis in human hepatoma HepG2 cells', World Journal of Gastroenterology. doi:10.3748/wjg.14.511 Preclinical
https://doi.org/10.3748/wjg.14.511 - Nakajima, Y. and Sato, Y. and Konishi, T (2007) 'Antioxidant Small Phenolic Ingredients in Inonotus obliquus (persoon) Pilat (Chaga)', Chemical and Pharmaceutical Bulletin. doi:10.1248/cpb.55.1222 Preclinical
https://doi.org/10.1248/cpb.55.1222 - Kim, H. and Yoon, D. and Kim, C. and Shrestha, B. and Chang, W. and Lim, S. and Lee, W. and Han, S. and Lee, J. and Lim, M. and Kim, G. and Choi, S. and Song, W.O. and Sung, J. and Hwang, K (2007) 'Ethanol Extract of Inonotus obliquus Inhibits Lipopolysaccharide-Induced Inflammation in RAW 264.7 Macrophage Cells', Journal of Medicinal Food. doi:10.1089/jmf.2006.156 Preclinical
https://doi.org/10.1089/jmf.2006.156 - Mizuno, T. and Zhuang, C. and Abe, K. and Okamoto, H. and Kiho, T. and Ukai, S. and Leclerc, S. and Meijer, L (1999) 'Antitumor and Hypoglycemic Activities of Polysaccharides from the Sclerotia and Mycelia of Inonotus obliquus (Pers.: Fr.) Pil. (Aphyllophoromycetideae)', International journal of medicinal mushrooms. doi:10.1615/intjmedmushr.v1.i4.20 Preclinical
https://doi.org/10.1615/intjmedmushr.v1.i4.20 - Su, L. and Xin, C. and Yang, J. and Dong, L. and Mei, H. and Dai, X. and Wang, Q (2022) 'A polysaccharide from Inonotus obliquus ameliorates intestinal barrier dysfunction in mice with type 2 diabetes mellitus', International Journal of Biological Macromolecules. doi:10.1016/j.ijbiomac.2022.06.071 Preclinical
https://doi.org/10.1016/j.ijbiomac.2022.06.071 - Yang, M. and Hu, D. and Cui, Z. and Li, H. and Man, C. and Jiang, Y (2021) 'Lipid-Lowering Effects of Inonotus obliquus Polysaccharide In Vivo and In Vitro', Foods. doi:10.3390/foods10123085 Preclinical
https://doi.org/10.3390/foods10123085 - Wang, J. and Hu, W. and Li, L. and Huang, X. and Liu, Y. and Wang, D. and Teng, L (2017) 'Antidiabetic activities of polysaccharides separated from Inonotus obliquus via the modulation of oxidative stress in mice with streptozotocin-induced diabetes', PLoS ONE. doi:10.1371/journal.pone.0180476 Preclinical
https://doi.org/10.1371/journal.pone.0180476 - Giridharan, V.V. and Thandavarayan, R.A. and Konishi, T (2011) 'Amelioration of scopolamine induced cognitive dysfunction and oxidative stress by Inonotus obliquus– a medicinal mushroom', Food & Function. doi:10.1039/c1fo10037h Preclinical
https://doi.org/10.1039/c1fo10037h - Lee, J. and Hyun, C (2014) 'Insulin‐Sensitizing and Beneficial Lipid‐Metabolic Effects of the Water‐Soluble Melanin Complex Extracted from Inonotus obliquus', Phytotherapy Research. doi:10.1002/ptr.5131 Preclinical
https://doi.org/10.1002/ptr.5131 - Kim, Y (2005) 'Immunomodulatory Activity of the Water Extract from Medicinal MushroomInonotus obliquus', Mycobiology. doi:10.4489/myco.2005.33.3.158 Preclinical
https://doi.org/10.4489/myco.2005.33.3.158 - Géry, A., Dubreule, C., André, V., Rioult, J.P., Bouchart, V., Heutte, N., Eldin de Pécoulas, P., Krivomaz, T. and Garon, D (2018) 'Chaga (Inonotus obliquus), a future potential medicinal fungus in oncology? A chemical study and a comparison of the cytotoxicity against human lung adenocarcinoma cells (A549) and human bronchial epithelial cells (BEAS-2B)', 17(3), pp. 832--843. doi:10.1177/1534735418757912 Traditional / reference
https://doi.org/10.1177/1534735418757912 - Royal Botanic Gardens, Kew (n.d.). Available at: https://powo.science.kew.org Traditional / reference
https://powo.science.kew.org - Shashkina, M.Ya., Shashkin, P.N. and Sergeev, A.V (2006) 'Chemical and medicobiological properties of chaga', 40(10), pp. 560--568. Traditional / reference
https://scholar.google.com/scholar?q=Chemical%20and%20medicobiological%20properties%20of%20chaga - Duke, J.A (2002) 'Handbook of Medicinal Herbs, Second Edition'. Traditional / reference
https://scholar.google.com/scholar?q=Handbook%20of%20Medicinal%20Herbs%2C%20Second%20Edition
- Hammoodi, O.T., Alkhilani, M.A., Alhayani, W.A., Al-Nuaimy, W. and Tala'a, A.A (2024) 'Effects of Laurus nobilis Leaf Extract on Healing of Experimentally Induced Wounds in Rabbits', Veterinary Medicine International, 2024, pp. 2889480. doi:10.1155/2024/2889480 Preclinical
https://doi.org/10.1155/2024/2889480 - Caputo, L., Nazzaro, F., Souza, L.F., Aliberti, L., De Martino, L. and Fratianni, F (2017) 'Laurus nobilis: Composition of Essential Oil and Its Biological Activities', Molecules, 22(6), pp. 930. doi:10.3390/molecules22060930 Preclinical
https://doi.org/10.3390/molecules22060930 - Bourebaba, N., Kornicka-Garbowska, K., Marycz, K., Bourebaba, L. and Kowalczuk, A (2021) 'Laurus nobilis ethanolic extract attenuates hyperglycemia and hyperinsulinemia-induced insulin resistance in HepG2 cell line through the reduction of oxidative stress and improvement of mitochondrial biogenesis', Mitochondrion, 59, pp. 190-213. doi:10.1016/j.mito.2021.06.003 Preclinical
https://doi.org/10.1016/j.mito.2021.06.003 - Dobroslavic, E., Repajic, M., Dragovic-Uzelac, V. and Elez Garofulic, I (2022) 'Isolation of Laurus nobilis Leaf Polyphenols: A Review on Current Techniques and Future Perspectives', Foods, 11(2), pp. 235. doi:10.3390/foods11020235 Meta-analysis / review
https://doi.org/10.3390/foods11020235 - Chbili, C., Maoua, M., Zaouali, M., Selmi, M., Kacem, I. and Mrizek, N (2022) 'Evaluation of daily Laurus nobilis tea consumption on anxiety and stress biomarkers in healthy volunteers', Archives Italiennes de Biologie, 160(3-4), pp. 136-146. doi:10.12871/000398292022343 Clinical study
https://doi.org/10.12871/000398292022343 - Chbili, C., Maoua, M., Selmi, M., Mrad, S., Khairi, H. and Limem, K (2020) 'Evaluation of Daily Laurus nobilis Tea Consumption on Lipid Profile Biomarkers in Healthy Volunteers', Journal of the American College of Nutrition, 39(8), pp. 733-738. doi:10.1080/07315724.2020.1727787 Clinical study
https://doi.org/10.1080/07315724.2020.1727787 - Bouadid, I., Amssayef, A. and Eddouks, M (2023) 'Study of the Antihypertensive Effect of Laurus nobilis in Rats', Cardiovascular & Hematological Agents in Medicinal Chemistry, 21(1), pp. 42-54. doi:10.2174/1871525720666220512154041 Preclinical
https://doi.org/10.2174/1871525720666220512154041 - Mohammed, R.R., Omer, A.K., Yener, Z., Uyar, A. and Ahmed, A.K (2020) 'Biomedical effects of Laurus nobilis L. leaf extract on vital organs in streptozotocin-induced diabetic rats: Experimental research', Annals of Medicine and Surgery, 61, pp. 188-197. doi:10.1016/j.amsu.2020.11.051 Preclinical
https://doi.org/10.1016/j.amsu.2020.11.051 - Uchiyama, N., Matsunaga, K., Kiuchi, F., Honda, G., Tsubouchi, A. and Nakajima-Shimada, J (2002) 'Trypanocidal terpenoids from Laurus nobilis L', Chemical & Pharmaceutical Bulletin, 50(11), pp. 1514-1516. doi:10.1248/cpb.50.1514 Preclinical
https://doi.org/10.1248/cpb.50.1514 - Saab, A.M., Guerrini, A., Zeino, M., Wiench, B., Rossi, D. and Gambari, R (2015) 'Laurus nobilis L. Seed Extract Reveals Collateral Sensitivity in Multidrug-Resistant P-Glycoprotein-Expressing Tumor Cells', Nutrition and Cancer, 67(4), pp. 664-675. doi:10.1080/01635581.2015.1019632 Preclinical
https://doi.org/10.1080/01635581.2015.1019632 - Elansary HO, et al. Laurus nobilis: Composition of Essential Oil and Its Biological Activities. Biomolecules. 2018;8 (2018) ';8(3):98', 8(3). Available at: https://pmc.ncbi.nlm.nih.gov/articles/PMC6152719/ Traditional / reference
https://pmc.ncbi.nlm.nih.gov/articles/PMC6152719/ - Fernandes F, et al. Laurus nobilis Leaves and Fruits: A Review of Metabolite Composition and Interest in Human Health. Applied Sciences. 2023;13 (2023) ';13(7):4606', 13(7). Available at: https://www.mdpi.com/2076-3417/13/7/4606 Traditional / reference
https://www.mdpi.com/2076-3417/13/7/4606 - Ramos C, et al. Bay Leaf. In: Nonvitamin and Nonmineral Nutritional Supplements. Academic Press; 2019:269-276. https://pmc.ncbi.nlm.nih.gov/articles/PMC7152419/ (2019) ':269-276'. Available at: https://pmc.ncbi.nlm.nih.gov/articles/PMC7152419/ Traditional / reference
https://pmc.ncbi.nlm.nih.gov/articles/PMC7152419/ - Singletary KW. Bay Leaf: Potential Health Benefits. Nutrition Today. 2021;55 (2021) ';55(4):184-193', 55(4). Available at: https://journals.lww.com/nutritiontodayonline/fulltext/2021/07000/bay_leaf__potential_health_benefits.8.aspx Traditional / reference
https://journals.lww.com/nutritiontodayonline/fulltext/2021/07000/bay_leaf__potential_health_benefits.8.aspx - University of Arizona Campus Arboretum. Medicinal Plant Virtual Tour - Bay Laurel. https://arboretum.arizona.edu/medicinal-plant-virtual-tour-bay-laurel. Available at: https://arboretum.arizona.edu/medicinal-plant-virtual-tour-bay-laurel Traditional / reference
https://arboretum.arizona.edu/medicinal-plant-virtual-tour-bay-laurel - Duke, J.A (2002) 'Handbook of Medicinal Herbs, Second Edition'. Traditional / reference
https://scholar.google.com/scholar?q=Handbook%20of%20Medicinal%20Herbs%2C%20Second%20Edition - Malaspina, P. and Betuzzi, F. and Ingegneri, M. and Smeriglio, A. and Cornara, L. and Trombetta, D (2022) 'Risk of Poisoning from Garden Plants: Misidentification between Laurel and Cherry Laurel', Toxins, 14(11), pp. 726. doi:10.3390/toxins14110726 Preclinical
https://doi.org/10.3390/toxins14110726 - Henriet, M. and Auquiere, J.P. and Moens, P (1974) 'Analysis and content of hydrocyanic acid by cutting, row and organographic zone of leaves of cherry laurel (Prunus laurocerasus L)', Journal de Pharmacie de Belgique, 29(5), pp. 437-43. Available at: https://pubmed.ncbi.nlm.nih.gov/4377277/ Preclinical
https://pubmed.ncbi.nlm.nih.gov/4377277/
Generated automatically from the Omnia Sana plant database and its cited sources. For educational purposes only — not medical advice. Always consult a qualified practitioner before using medicinal plants.